Sign In
Buy AZN
$183.02
+2.00 (+1.10%)
At Close: Jun 24, 2026
AstraZeneca (AZN) Set to Acquire CinCor Pharma for $1.3B
09:47am, Tuesday, 10'th Jan 2023
AstraZeneca's (AZN) CinCor Pharma buyout is going to add blood pressure drug baxdrostat to its cardiorenal pipeline.
Ranking The Top 10 Pharmaceuticals By Pipeline
11:44pm, Monday, 09'th Jan 2023
The pipeline is the heart of a drug discovery company. As such, analyzing the health of a pipeline can lead to suggestions about future performance.
AstraZeneca To Acquire Blood-Pressure Drugmaker In $1.8 Billion Deal
10:46am, Monday, 09'th Jan 2023
AstraZeneca said it has agreed to buy CinCor Pharma, maker of clinical-stage blood pressure drug baxdrostat, in a deal valued at $1.8 billion. The post AstraZeneca To Acquire Blood-Pressure Drugmaker
AstraZeneca to acquire CinCor for US$1.8bn
07:09am, Monday, 09'th Jan 2023
AstraZeneca PLC (LSE:AZN) has announced it will acquire US-based biopharmaceutical firm CinCor for approximately US$1.8bn in an effort to boost its treatments of cardiorenal diseases. As part of the d
AstraZeneca to Buy CinCor Pharma in $1.8 Billion Deal
04:32am, Monday, 09'th Jan 2023
AstraZeneca said the deal, expected to close in the first quarter of 2023, will bolster its cardiorenal pipeline
AstraZeneca will buy U.S.-based CinCor for cardiorenal asset
02:29am, Monday, 09'th Jan 2023
AstraZeneca PLC said Monday that it has agreed to buy CinCor Pharma, Inc., acquiring global rights to the latter's baxdrostat cardiorenal drug for an upfront transaction value of around $1.3 billion.
AstraZeneca to buy U.S.-based CinCor Pharma in $1.8 bln deal
02:16am, Monday, 09'th Jan 2023
AstraZeneca said on Monday it will buy U.S.-based clinical-stage biopharmaceutical firm CinCor Pharma Inc in a deal valued at about $1.8 billion to strengthen its pipeline of heart and kidney drugs.
AstraZeneca's COVID drug Evusheld unlikely to neutralize newest variant, FDA says
04:50pm, Friday, 06'th Jan 2023
The Food and Drug Administration late Friday said that AstraZeneca Plc's AZN, +1.42% COVID-19 drug Evusheld may not provide protection against developing the illness in people exposed to XBB.1.5, one
FDA Accepts AstraZeneca (AZN), Sanofi's RSV Antibody BLA
03:03pm, Friday, 06'th Jan 2023
The FDA's decision on AstraZeneca (AZN)/Sanofi's (SNY) regulatory filing, seeking approval for using their RSV antibody in all infants, is expected in third-quarter 2023.
1 Stock Defying the Downturn to Buy, and 1 to Avoid
09:53am, Friday, 06'th Jan 2023
These two stocks might go in different directions in the future.
GSK, AstraZeneca: Will the two UK drugs giants ride the US$74bn pharma wave or will they be left beached?
07:54am, Friday, 06'th Jan 2023
The global pharma sector is expected to see clinical trial readouts that could potentially de-risk approximately US$74bn of peak sales in 2023, according to a research report from Credit Suisse, This
AstraZeneca: Has the market factored in the full value of potential cancer blockbuster?
05:58am, Thursday, 05'th Jan 2023
A phase III clinical trial of a lung cancer drug developed by AstraZeneca PLC (LSE:AZN) and Daiichi Sankyo is expected to show positive results, according to a leading investment bank. The treatment,
AstraZeneca Dato-DXd TL01 study data expected to be a high positive "which should unlock multi-blockbuster potential" - analysts
05:05am, Thursday, 05'th Jan 2023
Ahead of Dato-DXd TL01 study data, expected to be published by AstraZeneca PLC (LSE:AZN) by the end of Q1 2023, analysts at JPMorgan see a high positive "which should unlock multi-blockbuster potent
Which Stocks Show Thick Skin As Bears Sink Fangs Into New Year?
08:05am, Wednesday, 04'th Jan 2023
As last year's bear market spills over into 2023, breakout index stocks like CAT, BOX, AZN and ELF stock show resilience. The post Which Stocks Show Thick Skin As Bears Sink Fangs Into New Year?
100 Best Stocks Of 2022: Oil Stocks And Medicals Shine
06:00pm, Friday, 30'th Dec 2022
Medical and energy companies, including oil stocks, lead the list of the 100 best stocks in 2022. The post 100 Best Stocks Of 2022: Oil Stocks And Medicals Shine appeared first on Investor's Business
